Terbinafine Hydrochloride
- Product NDC
- 70934-947
- 11-digit product format
- 709340947
- Labeler code
- 70934
- Product ID
- 70934-947_d722fcda-a6f2-18ba-e053-2a95a90a7de8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terbinafine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA077714
- Marketing category
- ANDA
- Marketing start
- 2022-02-03
- Marketing end
- 0000-00-00
- Substance
- TERBINAFINE HYDROCHLORIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Allylamine Antifungal [EPC], Allylamine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 012C11ZU6G | TERBINAFINE HYDROCHLORIDE | 78628-80-5 | TERBINAFINE HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-947-45 | 70934094745 | 45 TABLET in 1 BOTTLE, PLASTIC (70934-947-45) | 45 tablet | 2022-02-03 | 0000-00-00 | No | No | Current |